 |
Hu1D10, humanized monoclonal antibody |
|---|---|
| Trade Name | Remitogen |
| Orphan Indication | For use in the treatment of 1D10+ B cell non-Hodgkin's lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2001-11-28 00:00:00 |
| Sponsor | PDL BioPharma, Inc.;34801 Campus Drive;Fremont, California, 94555 |
